German company confirms marijuana agreement with Taliban regime

From Franca Quarneti, Via El Planteo

A few weeks ago, the Taliban regime in Afghanistan announced that it had reached an agreement with a company to cultivate and manufacture cannabis products in the country.

The Home Office reported on social media that a company called Cpharm would invest more than $ 400 million to build a marijuana factory.

Photo by Farid Ershad via Unsplash

What happened?

Media shit put a small consulting firm called Cpharm outside of Sydney, Australia in the spotlight. The company quickly issued a statement denying any relationship with the regime.

“We have no relationship with cannabis or the Taliban. We have no idea where the Taliban statement in the media came from and we want to assure everyone that it cannot be related to Cpharm Pty Ltd Australia, ”they said.

After the media hype, Taliban spokesman Qari Saeed Khosty tweeted to clarify the matter: The deal had been made with a German company dedicated to developing cannabinoid-based drugs called Cpharm.

The German company with an actual cannabis deal with Afghanistan

Cannabis Now contacted the Bonn office of CPharm International and spoke to its CEO Werner Zimmerman.

“We started talks with Afghanistan in 2017 when their parliament passed a law on medicinal cannabis,” Zimmerman said, adding: “In November 2020 we started building the infrastructure at Mazar-i-Sharif in the north of the country and brought in experts to build a laboratory. But the previous government set up by the Americans was very corrupt. “

RELATED: We need to realize that the war in Afghanistan is not our “longest war”

In addition, the CEO sees “better prospects” following the advance of the Taliban in August.

“The new government loves us very much,” he said.

“CPharm will operate contract growers and build an extraction center to process cannabis grown on properties by local landowners,” said Zimmerman. “Local growers get our seeds and meet our industry standards.”

This article originally appeared on El Planteo and was republished with permission.